Industry

Drug recall: Pfizer recalls some batches of Blood Pressure drug due to this reason

Pfizer said there was no immediate risk to patients taking this medication, in which the agent, a nitrosamine, was found.

The Health Master

April 24, 2022

601

Last Updated on October 15, 2024 by The Health Master

Pfizer said on Friday it was voluntarily recalling five batches of its Accupril blood pressure tablets after finding elevated levels of a potential cancer-causing agent in the medicine.

The drugmaker said it was not aware of any reports of adverse events related to the recalled batches, which were distributed in the United States and Puerto Rico from December 2019 to April 2022.

Pfizer Canada also recalled all lots of three doses of Accupril on Thursday after finding the same impurity to be above acceptable levels.

Click for more articles on Drugs recall

Pfizer said there was no immediate risk to patients taking this medication, in which the agent, a nitrosamine, was found.

Nitrosamines are common in water and foods but exposure above acceptable levels over long periods of time could increase the risk of cancer.

Pfizer last month also recalled some batches of another blood pressure drug, Accuretic, and two authorized cheaper versions due to the presence of a possible carcinogen.

Other drugs recall

Drug recall: Insulin Glargine recalled due to this reason

Moderna recalls thousands of C-19 vaccine doses

Drug recall: Certain Products recalled due to Microbial Contamination

Drug Recall: IDArubicin Hydrochloride Injection recalled due to this reason

Drug recall: Orphenadrine Citrate 100 mg Extended Release Tablets recalled due to this reason

Drug recall: This drug recalled due to detection of NDMA

Also read

SEC of DCGI asked Bharat Biotech to provide more data on Covaxin for children aged below 12

Govt working on policy to boost R&D in Pharma Sector

USFDA gives tentative nod to Alembic Pharma for Ivabradine tablets

NPPA to set up digital platform to track availability of essential…